A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Clinical trial NCT07610278 · RECRUITING
Trial details
- NCT number
- NCT07610278
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-29
- Primary completion
- 2027-04-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.